Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: the BMT CTN-0903/AMC-080 Trial.

Ambinder RF, Wu J, Logan B, Durand CM, Shields R, Popat UR, Little RF, McMahon DK, Cyktor J, Mellors JW, Ayala E, Kaplan LD, Noy A, Jones RJ, Howard A, Forman SJ, Porter D, Arce-Lara C, Shaughnessy P, Sproat L, Hashmi SK, Mendizabal AM, Horowitz MM, Navarro WH, Alvarnas JC.

Biol Blood Marrow Transplant. 2019 Jul 4. pii: S1083-8791(19)30417-3. doi: 10.1016/j.bbmt.2019.06.033. [Epub ahead of print]

PMID:
31279752
2.

First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors.

Tao JJ, Cangemi NA, Makker V, Cadoo KA, Liu JF, Rasco DW, Navarro WH, Haqq CM, Hyman DM.

Clin Cancer Res. 2019 Sep 15;25(18):5458-5465. doi: 10.1158/1078-0432.CCR-19-1065. Epub 2019 May 8.

PMID:
31068369
3.

Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results.

Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Ball ED, Bolwell BJ, Bunin NJ, Cheerva A, Delgado DC, Dvorak CC, Gillio AP, Hahn TE, Hale GA, Haight AE, Hayes-Lattin BM, Kasow KA, Linenberger M, Magalhaes-Silverman M, Mori S, Prasad VK, Quigg TC, Sahdev I, Schriber JR, Shenoy S, Tse WT, Yanik GA, Navarro WH, Horowitz MM, Confer DL, Shaw BE, Switzer GE.

Biol Blood Marrow Transplant. 2019 May;25(5):955-964. doi: 10.1016/j.bbmt.2018.12.765. Epub 2018 Dec 31.

PMID:
30605731
4.

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL.

Biol Blood Marrow Transplant. 2019 Apr;25(4):699-711. doi: 10.1016/j.bbmt.2018.11.004. Epub 2018 Nov 10.

PMID:
30423480
5.

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.

Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman OF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE.

Haematologica. 2019 Apr;104(4):844-854. doi: 10.3324/haematol.2018.200121. Epub 2018 Oct 31.

6.

Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial.

Alvarnas JC, Le Rademacher J, Wang Y, Little RF, Akpek G, Ayala E, Devine S, Baiocchi R, Lozanski G, Kaplan L, Noy A, Popat U, Hsu J, Morris LE Jr, Thompson J, Horowitz MM, Mendizabal A, Levine A, Krishnan A, Forman SJ, Navarro WH, Ambinder R.

Blood. 2016 Aug 25;128(8):1050-8. doi: 10.1182/blood-2015-08-664706. Epub 2016 Jun 13.

7.

Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia.

Barker JN, Fei M, Karanes C, Horwitz M, Devine S, Kindwall-Keller TL, Holter J, Adams A, Logan B, Navarro WH, Riches M; RCI BMT 05-DCB Protocol Team.

Br J Haematol. 2015 Feb;168(3):405-12. doi: 10.1111/bjh.13136. Epub 2014 Oct 1.

8.

Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.

Pulsipher MA, Chitphakdithai P, Logan BR, Navarro WH, Levine JE, Miller JP, Shaw BE, O'Donnell PV, Majhail NS, Confer DL.

Blood. 2014 Jun 5;123(23):3655-63. doi: 10.1182/blood-2013-12-542464. Epub 2014 Apr 15.

9.

Towards a global system of vigilance and surveillance in unrelated donors of haematopoietic progenitor cells for transplantation.

Shaw BE, Chapman J, Fechter M, Foeken L, Greinix H, Hwang W, Phillips-Johnson L, Korhonen M, Lindberg B, Navarro WH, Szer J.

Bone Marrow Transplant. 2013 Nov;48(12):1506-9. doi: 10.1038/bmt.2013.104. Epub 2013 Jul 29.

PMID:
23892330
10.

Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.

Pulsipher MA, Chitphakdithai P, Logan BR, Shaw BE, Wingard JR, Lazarus HM, Waller EK, Seftel M, Stroncek DF, Lopez AM, Maharaj D, Hematti P, O'Donnell PV, Loren AW, Leitman SF, Anderlini P, Goldstein SC, Levine JE, Navarro WH, Miller JP, Confer DL.

Blood. 2013 Jan 3;121(1):197-206. doi: 10.1182/blood-2012-03-417667. Epub 2012 Oct 29. Erratum in: Blood. 2014 Mar 20;123(12):1970.

11.

National marrow donor program session: donor issues.

Navarro WH, Switzer GE, Pulsipher M.

Biol Blood Marrow Transplant. 2013 Jan;19(1 Suppl):S15-9. doi: 10.1016/j.bbmt.2012.10.019. Epub 2012 Oct 17. Review. No abstract available.

12.

Infusion of autologous peripheral blood stem cells in an unrelated donor who developed severe aplastic anemia following stem cell donation.

Frangoul H, Navarro WH, Confer DL, Jagasia M.

Bone Marrow Transplant. 2012 Jun;47(6):869. doi: 10.1038/bmt.2011.174. Epub 2011 Aug 29. No abstract available.

PMID:
21874062
13.

Obesity and lymphoma therapy: not a bad combination after all.

Navarro WH, Loberiza FR.

Leuk Lymphoma. 2010 Sep;51(9):1590-1. doi: 10.3109/10428194.2010.512096. No abstract available.

PMID:
20807091
14.

Donor policies for stem cell transplantation.

Navarro WH.

JAMA. 2010 Aug 4;304(5):525. doi: 10.1001/jama.2010.1074. No abstract available.

PMID:
20682931
15.

Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults.

Navarro WH, Agovi MA, Logan BR, Ballen K, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Ho VT, Juckett M, Lazarus HM, Litzow MR, Liesveld JL, Moreb JS, Marks DI, McCarthy PL, Pasquini MC, Rizzo JD.

Biol Blood Marrow Transplant. 2010 Oct;16(10):1442-50. doi: 10.1016/j.bbmt.2010.04.009. Epub 2010 Apr 20.

16.

Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation.

Loberiza FR Jr, Lee SJ, Freytes CO, Giralt SA, Van Besien K, Kurian S, del Cerro P, Toro JJ, Williams LA, Ketelsen SW, Navarro WH, Rizzo JD.

Biol Blood Marrow Transplant. 2009 Aug;15(8):903-9. doi: 10.1016/j.bbmt.2009.04.005.

17.

Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.

Smith SM, van Besien K, Carreras J, Bashey A, Cairo MS, Freytes CO, Gale RP, Hale GA, Hayes-Lattin B, Holmberg LA, Keating A, Maziarz RT, McCarthy PL, Navarro WH, Pavlovsky S, Schouten HC, Seftel M, Wiernik PH, Vose JM, Lazarus HM, Hari P.

Biol Blood Marrow Transplant. 2008 Aug;14(8):904-12. doi: 10.1016/j.bbmt.2008.05.021.

18.

Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.

Navarro WH, Loberiza FR Jr, Bajorunaite R, van Besien K, Vose JM, Lazarus HM, Rizzo JD.

Biol Blood Marrow Transplant. 2006 May;12(5):541-51.

19.

Myelodysplastic syndromes clinical practice guidelines in oncology.

Greenberg PL, Baer MR, Bennett JM, Bloomfield CD, De Castro CM, Deeg HJ, Devetten MP, Emanuel PD, Erba HP, Estey E, Foran J, Gore SD, Millenson M, Navarro WH, Nimer SD, O'Donnell MR, Saba HI, Spiers K, Stone RM, Tallman MS.

J Natl Compr Canc Netw. 2006 Jan;4(1):58-77. No abstract available. Erratum in: J Natl Compr Canc Netw. 2006 Mar;4(3):table of contents. Dosage error in article text.

PMID:
16403405
20.

Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minorities.

Schwake CJ, Eapen M, Lee SJ, Freytes CO, Giralt SA, Navarro WH, Rizzo JD, van Besien K, Loberiza FR Jr.

Biol Blood Marrow Transplant. 2005 Dec;11(12):988-98.

21.

AIDS-related lymphoproliferative disease.

Navarro WH, Kaplan LD.

Blood. 2006 Jan 1;107(1):13-20. Epub 2005 Aug 11. Review.

PMID:
16099881
22.

Impact of obesity in the setting of high-dose chemotherapy.

Navarro WH.

Bone Marrow Transplant. 2003 Jun;31(11):961-6. Review.

PMID:
12774045

Supplemental Content

Loading ...
Support Center